222 related articles for article (PubMed ID: 15825167)
1. Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
Int J Cancer; 2005 Sep; 116(4):624-33. PubMed ID: 15825167
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein 70 gene therapy combined with hyperthermia using magnetic nanoparticles.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Gene Ther; 2003 Dec; 10(12):918-25. PubMed ID: 14712318
[TBL] [Abstract][Full Text] [Related]
3. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes.
Suzuki M; Shinkai M; Honda H; Kobayashi T
Melanoma Res; 2003 Apr; 13(2):129-35. PubMed ID: 12690295
[TBL] [Abstract][Full Text] [Related]
4. Heat immunotherapy using magnetic nanoparticles and dendritic cells for T-lymphoma.
Tanaka K; Ito A; Kobayashi T; Kawamura T; Shimada S; Matsumoto K; Saida T; Honda H
J Biosci Bioeng; 2005 Jul; 100(1):112-5. PubMed ID: 16233860
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection of dendritic cells in combination with local hyperthermia induces systemic antitumor effect in patients with advanced melanoma.
Guo J; Zhu J; Sheng X; Wang X; Qu L; Han Y; Liu Y; Zhang H; Huo L; Zhang S; Lin B; Yang Z
Int J Cancer; 2007 Jun; 120(11):2418-25. PubMed ID: 17294445
[TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.
Lee TH; Cho YH; Lee JD; Yang WI; Shin JL; Lee MG
Immunol Lett; 2006 Jul; 106(1):19-26. PubMed ID: 16647143
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma.
Ito A; Matsuoka F; Honda H; Kobayashi T
Cancer Immunol Immunother; 2004 Jan; 53(1):26-32. PubMed ID: 14551746
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles.
Ito A; Shinkai M; Honda H; Yoshikawa K; Saga S; Wakabayashi T; Yoshida J; Kobayashi T
Cancer Immunol Immunother; 2003 Feb; 52(2):80-8. PubMed ID: 12594571
[TBL] [Abstract][Full Text] [Related]
9. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity].
You J; Wang CL; Hao XS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effect of hyperthermia on prostate cancer mediated by magnetite cationic liposomes and immune-response induction in transplanted syngeneic rats.
Kawai N; Ito A; Nakahara Y; Futakuchi M; Shirai T; Honda H; Kobayashi T; Kohri K
Prostate; 2005 Sep; 64(4):373-81. PubMed ID: 15754344
[TBL] [Abstract][Full Text] [Related]
11. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
Bachleitner-Hofmann T; Strohschneider M; Krieger P; Sachet M; Dubsky P; Hayden H; Schoppmann SF; Pfragner R; Gnant M; Friedl J; Stift A
J Clin Endocrinol Metab; 2006 Nov; 91(11):4571-7. PubMed ID: 16954161
[TBL] [Abstract][Full Text] [Related]
12. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
[TBL] [Abstract][Full Text] [Related]
13. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
[TBL] [Abstract][Full Text] [Related]
14. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
15. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
16. Optimization of hyperthermia and dendritic cell immunotherapy for squamous cell carcinoma.
Matsumoto K; Yamamoto N; Hagiwara S; Saito M; Furue H; Shigetomi T; Narita Y; Mitsudo K; Tohnai I; Kobayashi T; Ueda M
Oncol Rep; 2011 Jun; 25(6):1525-32. PubMed ID: 21455579
[TBL] [Abstract][Full Text] [Related]
17. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
[TBL] [Abstract][Full Text] [Related]
18. Targeted hyperthermia using magnetite cationic liposomes and an alternating magnetic field in a mouse osteosarcoma model.
Shido Y; Nishida Y; Suzuki Y; Kobayashi T; Ishiguro N
J Bone Joint Surg Br; 2010 Apr; 92(4):580-5. PubMed ID: 20357339
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effect of dendritic cells loaded with a fusion mRNA encoding tyrosinase-related protein 2 and enhanced green fluorescence protein on B16 melanoma.
Fukui M; Nakano-Hashimoto T; Okano K; Maruta Y; Suehiro Y; Hamanaka Y; Yamashita H; Imai K; Kawano MM; Hinoda Y
Tumour Biol; 2004; 25(5-6):252-7. PubMed ID: 15627888
[TBL] [Abstract][Full Text] [Related]
20. Localized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity.
Mukhopadhaya A; Mendecki J; Dong X; Liu L; Kalnicki S; Garg M; Alfieri A; Guha C
Cancer Res; 2007 Aug; 67(16):7798-806. PubMed ID: 17699785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
